Phenoxodiol, a novel isoflavone derivative, inhibits dimethylbenz[a]anthracene (DMBA)-induced mammary carcinogenesis in female Sprague-Dawley rats

European Journal of Cancer

Volumn 39, Issue 7, 2003, Pages 1012-1018

  Constantinou, A I ^a,b,c   Mehta, R ^a,b   Husband, A ^d  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF CYPRUS   (Cyprus)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d Novogen Limited   (Australia)

Author keywords

Cancer incidence; Cancer prevention and carcinogen; Chemoprevention; Diet; Mammary tumours; Phenoxodiol

Indexed keywords

2H 1 BENZOPYRAN 7 O 1,3 (4 HYDROXYPHENYL); ANTINEOPLASTIC AGENT; DIMETHYLBENZ[A]ANTHRACENE; ISOFLAVONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL MODEL; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INCIDENCE; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIETARY INTAKE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

EID: 0037403574     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(03)00124-2     Document Type: Article

References (30)

1. Fisher B., Costantino J.P., Wickerham D.L.et al. Tamoxifen for prevention of breast cancer. report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J. Natl. Cancer Inst. 90:1998;1371-1388.
2. Redlich C.A., Blaner W.S., Van Bennekum A.M.et al. Effect of supplementation with beta-carotene and vitamin A on lung nutrient levels. Cancer Epidemiol. Biomarkers Prev. 7:1998;211-214.
3. Steele V.E., Sharma S., Mehta R.et al. Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals. J. Cell Biochem. Suppl. 26:1996;29-53.
4. Messina M., Barnes S. The role of soy products in reducing risk of cancer. J. Natl. Cancer Inst. 83:1991;541-546.
5. Constantinou A.I., Rossi H., Lantvit D.et al. Soy protein isolate prevents chemically induced rat mammary tumors. Pharm. Biol. 40:2002;24-34.
6. Barnes S., Grubbs C., Setchel K.D.R. Soybeans inhibit mammary tumors in models of breast cancer. Pariza M. Mutagens and Carcinogens in the Diet. 1990;239-253 Wiley-Liss, New York.
7. Constantinou A.I., Lantvit D., Hawthorne M., Xu X., van Breemen R.B., Pezzuto J.M. Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats. Nutr. Cancer. 41:2001;75-81.
8. Murrill W.B., Brown N.M., Zhang J.X., Manzolillo P.A., Barnes S., Lamartiniere C.A. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis. 17:1996;1451-7457.
9. Lamartiniere C.A., Cotroneo M.S., Fritz W.A., Wang J., Mentor-Marcel R., Elgavish A. Genistein chemoprevention. timing and mechanisms of action in murine mammary and prostate J. Nutr. 132:2002;552S-558S.
10. Ju Y.H., Allred C.D., Allred K.F., Karko K.L., Doerge D.R., Helferich W.G. Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr. 131:2001;2957-2962.
11. Martin P.M., Horwitz K.B., Ryan D.S., McGuire W.L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology. 103:1978;1860-1867.
12. Mehta R.G., Moriarty R.M., Mehta R.R.et al. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5. J. Natl. Cancer Inst. 89:1997;212-218.
13. Peto R., Pike M.C., Armitage P.et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br. J. Cancer. 35:1977;1-39.
14. Lin F.K., Banerjee M.R., Crump L.R. Cell cycle-related hormone carcinogen interaction during chemical carcinogen induction of nodule-like mammary lesions in organ culture. Cancer Res. 36:1976;1607-1614.
15. Senderowicz A.M., Headlee D., Stinson S.F.et al. Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms. J. Clin. Oncol. 16:1998;2986-2999.
16. Hawthorne M., Steele V., Mehta R.G. Evaluation of selected chemopreventive agents present in common foods in mouse mammary gland organ culture. Pharm. Biol. 40:2002;70-74.
17. Kelloff G.J., Boone C.W., Steele V.E.et al. Mechanistic considerations in the evaluation of chemopreventive data. IARC Sci. Publ. 139:1996;203-219.
18. Moon R.C., Constantinou A.I. Dietary retinoids and carotenoids in rodent models of mammary tumorigenesis. Breast Cancer Res. Treat. 46:1997;181-189.
19. McCormick D.L., Mehta R.G., Thompson C.A., Dinger N., Caldwell J.A., Moon R.C. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy. Cancer Res. 42:1982;508-5012.
20. Jordan V.C. Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata. Eur. J. Cancer. 12:1976;419-424.
21. Zujewski J. Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention. Environ. Mol. Mutagen. 39:2002;264-270.
22. Kelloff G.J., Boone C.W., Crowell J.A.et al. New agents for cancer chemoprevention. J. Cell. Biochem. Suppl. 26:1996;1-28.
23. Hollingsworth A.B., Lerner M.R., Lightfoot S.A.et al. Prevention of DMBA-induced rat mammary carcinomas comparing leuprolide, oophorectomy, and tamoxifen. Breast Cancer Res. Treat. 47:1998;63-70.
24. Constantinou A.I., Mehta R.G., Vaughan A. Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res. 16:1996;3293-3298.
25. Constantinou A.I., Husband A. Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable comple. Anticancer Res. 22:2002;2581-2585.
26. Cho K.H., Pezzuto J.M., Bolton J.L.et al. Selection of cancer chemopreventive agents based on inhibition of topoisomerase II activity. Eur. J. Cancer. 36:2000;2146-2156.
27. Uemura T., Ohkura H., Adachi Y., Morino K., Shiozaki K., Yanagida M. DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe. Cell. 50:1987;917-925.
28. Constantinou A.I., Vaughan A.T., Yamasaki H., Kamath N. Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation. Cancer Res. 56:1996;4192-4199.
29. Hasinoff B.B., Abram M.E., Barnabe N., Khelifa T., Allan W.P., Yalowich J.C. The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces differentiation and apoptosis in human leukemia K562 cells. Mol. Pharmacol. 59:2001;453-461.
30. Hutson T.E., Mekhail T., Weiss P.et al. Phase I study of phenoxodiol given by constant intravenous infusion in patients with solid neoplasms refractory to standard therapy. Proc. Am. Assoc. Cancer Res. 43:2002;553.